Ling Dong

机构：Beijing University of Chinese Medicine, Zhongshan Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-5995-7673

发表论文 180 篇 · 总被引 6472 次 · h-index 46

代表论文

• Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma (2024 · Journal for ImmunoTherapy of Cancer · 被引 39)
• Clinical applications and perspectives of circulating tumor DNA in gastric cancer (2024 · Cancer Cell International · 被引 22)
• Activation of NOD1 on tumor-associated macrophages augments CD8 + T cell–mediated antitumor immunity in hepatocellular carcinoma (2024 · Science Advances · 被引 20)
• Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma (2024 · International Journal of Biological Sciences · 被引 18)
• DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC (2024 · Cellular and Molecular Gastroenterology and Hepatology · 被引 16)
• Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway (2023 · Hepatology International · 被引 15)